Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Jan 24, 2024 2:43am
301 Views
Post# 35842266

RE:RE:Is a 25% No Response rate inevitable ?

RE:RE:Is a 25% No Response rate inevitable ?Funny this question came up, because I've been cogitating on it myself...
It's struck me, while asking myself to think of reasons why TLT may not succeed, that we are moving in direct opposition to the profit models of the entire medical industry.
Simply put... urologists are paid, not to cure cancer, but to treat it.
So, although our non-toxic, one-to-two-outpatient-visit treatment fulfills all the criteria for a major medical success, it actually pisses off the current industry of cancer profiteers, and could even force them into other specializations.
Hospitals will empty.
Purveyors of bandages, pain-relief drugs and IVs will suffer.
Can you see why seeking a JV with that network of urologists in the US (an idea abandoned a few years ago for "unknown" reasons) was doomed to fail?
Urologists in America need to see their patients repeatedly to maximize their profits.
So we have to tread carefully if we want our cure for cancer to pass the "commercialization" test.
Big Pharma needs to be kept at bay - they have too much to lose.
The only way this will make profits for us is to face the wind, create our own, cancer-cure based Canadian Pharma-tech giant, and damn the torpedoes!
No other course of action can succeed.
IMO, of course,


<< Previous
Bullboard Posts
Next >>